Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Capri, G."" wg kryterium: Autor


Tytuł :
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report and literature overview.
Autorzy :
Zattarin E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Nichetti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Bianchi G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Capri G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.; Oncology and Haemato-Oncology Department, University of Milan, Italy.
Pokaż więcej
Źródło :
Tumori [Tumori] 2020 Dec 09, pp. 300891620976981. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.
Autorzy :
Lobefaro R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Zattarin E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Nichetti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Brambilla M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Sepe P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Corti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Peverelli G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ottini A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Beninato T; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mazzeo L; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Rea CG; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mariani G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Bianchi GV; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Vernieri C; Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Capri G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło :
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Dec 07; Vol. 12, pp. 1758835920970081. Date of Electronic Publication: 2020 Dec 07 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.
Autorzy :
Gennaro M; Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. Electronic address: .
Listorti C; Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Mariani L; Department of Clinical Epidemiology and Trials Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Maccauro M; Nuclear Medicine Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Bianchi G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Capri G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Maugeri I; Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Lozza L; Radiation Therapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
De Santis MC; Radiation Therapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Folli S; Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Nov 01. Date of Electronic Publication: 2020 Nov 01.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Sentinel Node Biopsy alone or with Axillary Dissection in Breast Cancer Patients after Primary Chemotherapy: Long-term Results of a Prospective Interventional Study.
Autorzy :
Martelli G; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Barretta F; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Miceli R; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Folli S; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Maugeri I; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Listorti C; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Scaperrotta G; Breast Unit, Imaging, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Baili P; Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pruneri G; Breast Unit, Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capri G; Breast Unit, Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ferraris C; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło :
Annals of surgery [Ann Surg] 2020 Oct 15. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Autorzy :
Borreani C; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Alfieri S; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, .
Infante G; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Miceli R; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mariani P; Clinica Polispecialistica San Carlo, Paderno Dugnano, Milan, Italy.
Bosisio M; Clinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Vernieri C; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Bianchi GV; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capri G; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło :
Oncology [Oncology] 2020 Sep 29, pp. 1-12. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
175P Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)–positive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy
Autorzy :
Ligorio, F.
Pokaż więcej
Źródło :
In Abstract Book of the ESMO Virtual Congress2020 19 - 21 September / 16 - 18 October 2020, Annals of Oncology September 2020 31 Supplement 4:S312-S312
Czasopismo naukowe
Tytuł :
300P Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study
Autorzy :
Zattarin, E.
Pokaż więcej
Źródło :
In Abstract Book of the ESMO Virtual Congress2020 19 - 21 September / 16 - 18 October 2020, Annals of Oncology September 2020 31 Supplement 4:S362-S363
Czasopismo naukowe
Tytuł :
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Autorzy :
Cavazza M; Centre for Research on Health and Social Care Management (Cergas), SDA Bocconi School of Management, Milan, Italy. .
Banks H; Centre for Research on Health and Social Care Management (Cergas), SDA Bocconi School of Management, Milan, Italy.
Ercolanoni M; ARIA SpA (Azienda Regionale per L'Innovazione e gli Acquisti), Milan, Italy.
Cukaj G; ARIA SpA (Azienda Regionale per L'Innovazione e gli Acquisti), Milan, Italy.
Bianchi G; SC Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capri G; SC Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Longo F; Centre for Research on Health and Social Care Management (Cergas), SDA Bocconi School of Management, Milan, Italy.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Aug; Vol. 183 (1), pp. 189-199. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications.
Autorzy :
Vernieri C; IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy. .; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy. .
Corti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Nichetti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Manglaviti S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Zattarin E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Rea CG; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Capri G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
Bianchi GV; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.
de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, 20122, Milan, Italy.
Pokaż więcej
Źródło :
Breast cancer research : BCR [Breast Cancer Res] 2020 Apr 06; Vol. 22 (1), pp. 33. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Mechanistic Target of Rapamycin Complex 1/*metabolism
Phosphatidylinositol 3-Kinases/*metabolism
Proto-Oncogene Proteins c-akt/*metabolism
Receptor, ErbB-2/*metabolism
Androstadienes/administration & dosage ; Breast Neoplasms/pathology ; Clinical Trials as Topic ; Everolimus/administration & dosage ; Female ; Humans ; Multicenter Studies as Topic ; Neoplasm Metastasis ; Patient Safety ; Prospective Studies ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.
Autorzy :
Vernieri C; Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Via Adamello 16, 20133 Milan, Italy.; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Prisciandaro M; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Nichetti F; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Lobefaro R; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Peverelli G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Ligorio F; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Zattarin E; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Cona MS; ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy, Via G.B. Grassi 74, 20133 Milan, Italy.
Sepe P; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Corti F; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Manglaviti S; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Brambilla M; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Re B; SC Pharmacy, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Belfiore A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Pruneri G; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20133 Milan, Italy.
Celio L; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Mariani G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Bianchi GV; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Capri G; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
de Braud F; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20133 Milan, Italy.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Mar 06; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of Intensive vs Standard Blood Pressure Treatment Upon Erectile Function in Hypertensive Men: Findings From the Systolic Blood Pressure Intervention Trial.
Autorzy :
Foy CG; Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: .
Newman JC; Division of Public Health Sciences, Department of Biostatistic and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Russell GB; Division of Public Health Sciences, Department of Biostatistic and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Berlowitz DR; Bedford VA Hospital, Bedford, MA, and Boston University School of Medicine and Boston University School of Public Health, Boston, MA, USA.
Bates JT; Michael E. DeBakey Veterans' Administration Medical Center, Houston, TX, USA.
Burgner AM; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
Carson TY; Division of Internal Medicine, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Chertow GM; Division of Nephrology, Department of Medicine, Stanford University, Stanford, CA, USA.
Doumas MN; Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
Hughes RY; University Hospitals Case Medical Center, Cleveland, OH, USA.
Kostis JB; Robert Wood Johnson Medical School, Rutgers University, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA.
Buren PV; Department of Internal Medicine, Dallas Veterans' Administration Medical Center and University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wadley VG; Division of Gerontology, Geriatrics and Palliative Care, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Pokaż więcej
Corporate Authors :
SPRINT Study Research Group
Źródło :
The journal of sexual medicine [J Sex Med] 2020 Feb; Vol. 17 (2), pp. 238-248. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Blood Pressure/*drug effects
Erectile Dysfunction/*physiopathology
Hypertension/*drug therapy
Penile Erection/*physiology
Aged ; Ethnic Groups ; Humans ; Incidence ; Male ; Middle Aged ; Self Report ; Systole
Czasopismo naukowe
Tytuł :
Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.
Autorzy :
Derington, Catherine G.
Gums, Tyler H.
Bress, Adam P.
Herrick, Jennifer S.
Greene, Tom H.
Moran, Andrew E.
Weintraub, William S.
Kronish, Ian M.
Morisky, Donald E.
Trinkley, Katy E.
Saseen, Joseph J.
Reynolds, Kristi
Bates, Jeffrey T.
Berlowitz, Dan R.
Chang, Tara I.
Chonchol, Michel
Cushman, William C.
Foy, Capri G.
Herring, Charles T.
Katz, Lois Anne
Pokaż więcej
Źródło :
Hypertension (0194911X); Aug2019, Vol. 74 Issue 2, p267-275, 9p
Czasopismo naukowe
Tytuł :
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives.
Autorzy :
Vernieri C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. Electronic address: .
Milano M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Brambilla M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mennitto A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Maggi C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cona MS; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Prisciandaro M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Fabbroni C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Celio L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mariani G; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Bianchi GV; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capri G; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milan, Italy. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2019 Jul; Vol. 139, pp. 53-66. Date of Electronic Publication: 2019 May 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Resistance, Neoplasm*
Antibodies, Monoclonal, Humanized/*therapeutic use
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*antagonists & inhibitors
Trastuzumab/*therapeutic use
Breast Neoplasms/pathology ; Female ; Humans ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies